SUN PHARMACEUTICAL INDUSTRIES INC recalls Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, ND…

Recall date

March 4, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0311-2025

FDA classification

Class III

Brand / firm

SUN PHARMACEUTICAL INDUSTRIES INC

Sold / distributed

Nationwide in the USA

Why it was recalled

Cross Contamination

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.